Welcome to our dedicated page for NATIONAL HEALTHCARE SEC filings (Ticker: NHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on NATIONAL HEALTHCARE's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into NATIONAL HEALTHCARE's regulatory disclosures and financial reporting.
Dodson Vicki L reported acquisition or exercise transactions in this Form 4 filing.
National Healthcare Corp senior vice president Vicki L. Dodson received an equity award of 1,082 shares of common stock. The award was granted at no cash cost to her and increased her directly held common stock to 11,371.5455 shares.
The 1,082 shares are restricted stock that vest over three years. One-third is scheduled to vest on January 1, 2027, another third on January 1, 2028, and the final third on January 1, 2029, encouraging longer-term alignment with the company.
Shelly Timothy J. reported acquisition or exercise transactions in this Form 4 filing.
National Healthcare Corp senior vice president of operations Timothy J. Shelly received an equity award of 1,294 shares of common stock on February 27, 2026. The award was granted at $0.00 per share, indicating a stock-based compensation grant rather than an open-market purchase.
The granted shares are restricted and follow a three-year vesting schedule. One-third of the award is scheduled to vest on January 1, 2027, another third on January 1, 2028, and the final third on January 1, 2029. The filing also lists existing stock options, showing post-transaction holdings of 2,400, 8,000, 11,000, and 14,000 options under various grants, all held directly.
National Healthcare Corp CEO Stephen Fowler Flatt reported several equity transactions involving company stock. He exercised options to acquire 5,000 shares of common stock on March 2, 2026, at an exercise price effectively recorded as $0.0000 per option, increasing his directly held common shares to 67,237.
As part of the same event, 3,585 shares of common stock were withheld by the company at a price of $171.1500 per share to cover tax obligations, reducing his direct holdings to 63,652 shares. The filing also shows updated direct holdings of multiple option grants under the 2020 Omnibus Equity Incentive Plan, with post-transaction option positions of 6,147, 10,000 and 20,000 options.
Flatt Stephen Fowler reported acquisition or exercise transactions in this Form 4 filing.
National Healthcare Corp CEO Stephen Fowler Flatt was granted 3,090 shares of common stock on February 27, 2026, as a stock award with no cash paid per share. The grant consists of restricted shares subject to a three-year vesting schedule.
The award vests in three equal installments of 33 1/3% on January 1 of 2027, 2028, and 2029. The Form 4 also reports several option-to-purchase-common-stock positions, with post-transaction holdings of 6,147, 10,000, 18,000, and 20,000 option shares held directly.
National Healthcare Corp reported that SVP and CFO Brian F. Kidd acquired 1,507 shares of common stock on a grant or award basis at $0.00 per share. Following this grant, his directly held common stock totals 25,224 shares.
The footnote explains these are restricted shares that vest over three years, with 33 1/3% vesting on 1/1/2027, another 33 1/3% on 1/1/2028, and the final 33 1/3% on 1/1/2029. The filing also lists existing options to purchase common stock held directly.
National Healthcare Corp reported that Senior VP & General Counsel Josh A. McCreary acquired 1,458 shares of common stock on a restricted basis. These restricted shares vest over three years, in equal 33 1/3% installments on January 1 of 2027, 2028, and 2029. Following this grant, he directly holds 11,400 common shares, along with multiple option awards to purchase common stock reported as existing holdings.
FLATT BEN ANDERSON SR reported acquisition or exercise transactions in this Form 4 filing.
National Healthcare Corp senior vice president and CIO Ben Anderson Flatt Sr. received a grant of 1,342 shares of common stock on February 27, 2026. These are restricted shares granted at $0.00 per share, increasing his directly held common stock to 15,459.0547 shares after the award.
The restricted shares vest over three years, with 33 1/3% vesting on January 1, 2027, another 33 1/3% on January 1, 2028, and the final 33 1/3% on January 1, 2029. The filing also reports option holdings to purchase common stock, with several option positions listed as directly owned holdings.
NATIONAL HEALTHCARE CORP director William A. Adams filed an initial statement of beneficial ownership on Form 3. This filing identifies him as a director of the company and establishes his reporting status for future insider transactions, but does not itself report any share purchases or sales.
National HealthCare Corporation reported strong 2025 results, with net operating revenues and grant income of $1,517,781,000 versus $1,307,382,000 in 2024, a 16.1% increase driven by higher same‑facility revenue and the White Oak acquisition.
GAAP net income attributable to NHC rose to $120,015,000 from $101,927,000, while adjusted net income increased to $104,067,000 from $76,862,000, a 35.4% gain. GAAP diluted EPS were $7.67 versus $6.53, and adjusted diluted EPS were $6.65 versus $4.93.
In the fourth quarter, GAAP net income attributable to NHC was $24,849,000 versus $6,081,000 a year earlier, and adjusted net income was $28,774,000 versus $25,954,000, up 10.9%. NHC also reduced current and long‑term debt to $40,000,000 from $137,000,000 and increased stockholders’ equity to $1,068,772,000.
National HealthCare Corporation reports on its 2025 business, highlighting a broad post‑acute and senior care platform across 9 states, focused on skilled nursing, assisted living, independent living, homecare, hospice and behavioral health hospitals.
As of December 31, 2025, the company operated 80 skilled nursing facilities with 10,329 licensed beds, 26 assisted living facilities with 1,413 units, 9 independent living facilities with 777 retirement apartments, 3 behavioral health hospitals, plus 34 homecare and 33 hospice agencies. Owned and leased skilled nursing facilities posted an 89.7% overall census in 2025. About 96.8% of 2025 net operating revenues came from healthcare services, with payer mix of 31% Medicare, 30% Medicaid, 12% managed care and 27% private pay and other.
NHC emphasizes quality, with 62.5% of its 80 skilled nursing centers rated 4 or 5 stars by CMS and an average rating of 3.83 versus the industry’s 2.95. It expanded via the August 2024 acquisition of White Oak Management’s portfolio of 15 skilled nursing, 2 assisted living and 4 independent living facilities plus a pharmacy.
The company details exposure to reimbursement and regulatory shifts, including CMS payment updates across skilled nursing, home health and hospice, supplemental Medicaid payments, and a significant lease dispute with major landlord National Health Investors that could affect future occupancy costs and facility control. NHC also outlines labor shortages, potential staffing mandates, climate and disaster risks, extensive healthcare and privacy regulation, and rising public‑company compliance demands.